NIKA PHARMACEUTICALS, INC (NIKA)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | - | - | - | 156 |
| Professional fees | 4,081 | 11,145 | 54,523 | 14,957 |
| General and administrative | 14,300 | 1,800 | 28,816 | 39,999 |
| Total operating expenses | 18,381 | 12,945 | 83,339 | 54,956 |
| Loss from operations | -18,381 | -12,945 | -83,339 | -54,800 |
| Loss before provision for income taxes | -18,381 | -12,945 | -83,339 | -54,800 |
| Provision for income taxes | - | - | - | - |
| Net loss | -18,381 | -12,945 | -83,339 | -54,800 |
| Earnings per share, basic | - | - | - | - |
| Earnings per share, diluted | - | - | - | - |
| Weighted average number of shares outstanding, basic | 1,026,406,001 | 1,026,371,000 | 1,018,519,500 | 1,018,519,500 |
| Weighted average number of shares outstanding, diluted | 1,026,406,001 | 1,026,371,000 | 1,018,519,500 | 1,018,519,500 |